VCP maintains nuclear size by regulating the DNA damage-associated MDC1-p53-autophagy axis in Drosophila

Ya-Chu Chang1,2, Yu-Xiang Peng1, Bo-Hua Yu1

  • 1Institute of Biotechnology, Department of Life Science, National Tsing Hua University, Hsinchu, Taiwan.

Nature Communications
|July 13, 2021
PubMed

Insights

Disrupting valosin-containing protein (VCP) function in Drosophila causes nuclear size increase by accumulating MDC1 and stabilizing p53A. This suggests VCP is crucial for maintaining nuclear size homeostasis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Nuclear size is physiologically significant and linked to malignant transformation.
  • The precise mechanisms underlying nuclear size anomalies remain unclear.

Purpose of the Study:

  • To investigate the role of valosin-containing protein (VCP/TER94) in regulating nuclear size.
  • To elucidate the molecular mechanisms connecting VCP function to nuclear size control.

Main Methods:

  • Expression of dominant-negative TER94 mutants in Drosophila photoreceptors.
  • Analysis of VCP, MDC1, and p53A protein levels and interactions.
  • Assessment of nuclear size changes and autophagic flux.

Main Results:

  • Disruption of VCP function leads to progressive nuclear size increase.
  • Loss of VCP function causes accumulation of MDC1, a VCP substrate.
  • MDC1 accumulation stabilizes p53A, contributing to nuclear enlargement.

Conclusions:

  • VCP is essential for maintaining nuclear size homeostasis.
  • VCP regulates nuclear size by controlling MDC1 and p53A levels.
  • Impaired VCP function may lead to aberrant nuclear size increase via disrupted autophagic flux.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.6K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K